19
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Increase of Immunoglobulin G3 Subclass is Related to Brain Autoantibody in Alzheimer's Disease but not in Down's Syndrome

&
Pages 95-101 | Received 12 Oct 1988, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Miyo K. Chatanaka, Dorsa Sohaei, Eleftherios P. Diamandis & Ioannis Prassas. (2023) Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis. Critical Reviews in Clinical Laboratory Sciences 60:6, pages 398-426.
Read now
Homaidan T. Alhomaidan, Naila Rasheed, Salem Almatrafi, Fahad H. Al-Rashdi & Zafar Rasheed. (2019) Bisphenol A modified DNA: A possible immunogenic stimulus for anti-DNA autoantibodies in systemic lupus erythematosus. Autoimmunity 52:7-8, pages 272-280.
Read now
Miroljub Popović, Maria Caballero-Bleda, Luis Puelles & Natalija Popović. (1998) Importance of Immunological and Inflammatory Processes in the Pathogenesis and THERAPY of Alzheimer's Disease. International Journal of Neuroscience 95:3-4, pages 203-236.
Read now

Articles from other publishers (14)

Sung-Mi Shim, Young Ho Koh, Jong-Hoon Kim & Jae-Pil Jeon. (2022) A combination of multiple autoantibodies is associated with the risk of Alzheimer’s disease and cognitive impairment. Scientific Reports 12:1.
Crossref
Monokesh K. Sen, Mohammed S. M. Almuslehi, Peter J. Shortland, David A. Mahns & Jens R. Coorssen. (2021) Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. International Journal of Molecular Sciences 22:14, pages 7377.
Crossref
Umar Yazdani, Sayed Zaman, Linda S Hynan, L Steven Brown, Richard B Dewey, David Karp & Dwight C German. (2016) Blood biomarker for Parkinson disease: peptoids. npj Parkinson's Disease 2:1.
Crossref
Yuri I. Arshavsky. (2014) Alzheimer Disease and Cellular Mechanisms of Memory Storage. Journal of Neuropathology & Experimental Neurology 73:3, pages 192-205.
Crossref
F. Sardi, L. Fassina, L. Venturini, M. Inguscio, F. Guerriero, E. Rolfo & G. Ricevuti. (2011) Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmunity Reviews 11:2, pages 149-153.
Crossref
S. Cetiner, O. Demirhan, T. C. Inal, D. Tastemir & Y. Sertdemir. (2010) Analysis of peripheral blood T‐cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. International Journal of Immunogenetics 37:4, pages 233-237.
Crossref
Eli C. Levin, Nimish K. Acharya, Min Han, Semah B. Zavareh, Jonathan C. Sedeyn, Venkateswar Venkataraman & Robert G. Nagele. (2010) Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown. Brain Research 1345, pages 221-232.
Crossref
Constantin Bouras, Beat M. Riederer, Enik? K?vari, Patrick R. Hof & Panteleimon Giannakopoulos. (2005) Humoral immunity in brain aging and Alzheimer's disease. Brain Research Reviews 48:3, pages 477-487.
Crossref
H. H. Fudenberg. (1996) Dialysable lymphocyte extract (DLyE) in infantile onset autism: A pilot study. Biotherapy 9:1-3, pages 143-147.
Crossref
Vijendra K. Singh, Yi-Yuan Yang & Edith A. Singh. (1992) Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients. Neuroscience Letters 147:1, pages 25-28.
Crossref
Maurice W. Dysken, Marcia D. Minichiello, James L. Hill, Stacy Skare, John T. Little, Susan E. Molchan & Trey Sunderland. (1992) Distribution of peripheral lymphocytes in Alzheimer patients and controls. Journal of Psychiatric Research 26:3, pages 213-218.
Crossref
Vijendra K. Singh. 1990. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques 383 393 .
Vijendra K. Singh & Reed P. Warren. 1990. Novel Approaches to the Treatment of Alzheimer’s Disease. Novel Approaches to the Treatment of Alzheimer’s Disease 213 220 .
H. Hugh Fudenberg & Vijendra K. Singh. (2008) Alzheimer's “syndrome”: Prognosis of subsets with different etiology and preliminary effects of immunotherapy. Drug Development Research 15:2-3, pages 165-174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.